Emmanuel Papadakis from Deutsche Bank retains his negative opinion on the stock with a Sell rating. The target price is unchanged and still at EUR 80. | October 26, 2021
Richard Vosser from JP Morgan retains his positive opinion on the stock with a Buy rating. The target price is increased from EUR 100 to EUR 105. | October 14, 2021
French healthcare group Sanofi has entered into a three-year collaboration deal with leading U.S. university Stanford over developing research projects to focus on autoimmune diseases and. | May 6, 2021
Message :
Required fields
BRIDGEWATER, N.J., April 26, 2021 /PRNewswire/ Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine, supporting the COVID-19 pandemic and vaccine supply needs.
Sanofi will leverage its established infrastructure and manufacturing expertise at its site in Ridgefield, NJ, to perform fill and finish of up to 200 million doses of Moderna s COVID-19 vaccine, starting in September 2021. Since the beginning of the pandemic, we have been mobilizing on multiple fronts and we showed solidarity across the industry , said Paul Hudson, Chief Executive Officer, Sanofi.
We are one of the few pharmaceutical companies to leverage many industrial partnerships to improve global supply and access to COVID-19 vaccines, while in parallel, also continuing to develop our two COVID-19 vaccine programs. I would also like to acknowledge the contributions of the Department of Health and Human Services, and th